Skip to content

Alkermes ALKS Total Revenue

Total Revenue at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$11.49B+2.6%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$1.07B+19.1%
AbbVie logo
AbbVieABBV
$15B+12.4%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$191.2M+57.4%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$246.09M+87.0%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$814.5M+42.2%

Segments

By product

See full
Vivitrol$112.43M
Aristada And Aristada Initio$93.82M
LYBALVI$92.36M
LUMRYZ$39.49M

By geography

See full
US$1.41B-5.5%
IE$1.29M+9.8%

Other financials

Income statement

See full
Gross profit$331.3M+28.8%
Operating income-$48.3M-450%
Net income-$66.5M-396%
EPS (diluted)-$0.40-408%

Balance sheet

See full
Cash & equivalents$351.6M-12.1%
Total debt$1.6B+2,034%
Total equity$1.8B+15.9%
Total assets$4.3B+105%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$4.1M-59.5%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$7.5B+9.7%
Enterprise value$8.73B+41.2%
P/E49.1×+29.7×
P/S4.8×+0.3×

Profitability

See full
Gross margin86.6%+2.2pp
Operating margin12.3%-13.6pp
Net margin9.8%-13.5pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity9.4%-16.1pp
Debt / equity0.9×+0.9×
Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alkermes's total revenue?
Alkermes (ALKS) reported total revenue of $392.91M in Q1 2026.
How has Alkermes's total revenue changed year-over-year?
Alkermes's total revenue increased by 28.2% year-over-year, from $306.51M to $392.91M.
What is the long-term trend for Alkermes's total revenue?
Over 4 years (2021 to 2025), Alkermes's total revenue has grown at a 5.9% compound annual growth rate (CAGR), from $1.17B to $1.48B.
What does total revenue mean?
The total amount of money generated from business operations before any expenses are deducted.
How do you interpret total revenue?
An increase indicates successful product commercialization or market expansion, while a decrease may signal competitive pressure or patent expirations.
How does total revenue compare across companies?
Standard across all biotech and pharmaceutical firms, typically compared against historical growth rates and consensus analyst estimates.